Scientists probe Brain's memory system in depression treatment trial
NCT ID NCT07139834
Summary
This early-stage study aims to understand how two medications—escitalopram (a common antidepressant) and memantine—affect a specific brain function called 'pattern separation,' which helps distinguish similar memories. Researchers will measure brain activity using MRI scans and track depression symptoms in 30 adults with major depression who are not currently on medication. The goal is to learn how these drugs might improve memory processing and reduce negative thinking patterns in depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York State Psychiatric Institute (NYSPI)
New York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.